Airway Medix S.A. (WSE:AWM)
Poland · Delayed Price · Currency is PLN 0.2550
-0.0060 (-2.30%)
Sep 25, 2026, 11:12 AM CET
Airway Medix Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 0.15 | 0 | 0.01 | 0.01 | 0.01 | 0.26 | |
Revenue Growth | 7250.00% | -66.67% | 0% | 100.00% | -97.67% | -12.58% |
Cost of Revenue | 0.19 | 0.05 | 0.02 | - | - | - |
Gross Profit | -0.04 | -0.05 | -0.01 | 0.01 | 0.01 | 0.26 |
Selling, General & Admin | 4.17 | 5.63 | 4.5 | 2.53 | 1.76 | 2.14 |
Other Operating Expenses | 8.4 | -0.71 | -0.11 | -0.07 | 0.1 | -0.26 |
Operating Expenses | 14.97 | 7.15 | 6.41 | 2.66 | 16.18 | 2.5 |
Operating Income | -15.01 | -7.2 | -6.41 | -2.65 | -16.18 | -2.25 |
Interest Expense | -2.52 | -1.65 | -0.73 | -2.05 | -0.63 | -0.67 |
Interest & Investment Income | 0.27 | 0.27 | 0.28 | 0.4 | 0.41 | 0.41 |
Currency Exchange Gain (Loss) | 0.62 | 0.62 | 0.27 | 1.14 | -0.84 | 0.59 |
Other Non Operating Income (Expenses) | -0.88 | -0.3 | -5.18 | -0.22 | -0.04 | -0.1 |
EBT Excluding Unusual Items | -17.51 | -8.24 | -11.77 | -3.38 | -17.28 | -2.02 |
Gain (Loss) on Sale of Investments | - | - | 0.01 | 0.1 | - | - |
Asset Writedown | 9.99 | 9.99 | 0.03 | - | 7.42 | - |
Other Unusual Items | - | - | - | - | 0.5 | 0.03 |
Pretax Income | -7.53 | 1.75 | -11.74 | -3.28 | -9.37 | -1.99 |
Income Tax Expense | - | - | - | - | -2.33 | 0.39 |
Net Income | -7.53 | 1.75 | -11.74 | -3.28 | -7.04 | -2.37 |
Net Income to Common | -7.53 | 1.75 | -11.74 | -3.28 | -7.04 | -2.37 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 90 | 88 | 74 | 61 | 58 | 58 |
Shares Outstanding (Diluted) | 90 | 93 | 74 | 73 | 58 | 58 |
Shares Change | 2.33% | 26.61% | 1.38% | 24.48% | - | - |
EPS (Basic) | -0.08 | 0.02 | -0.16 | -0.05 | -0.12 | -0.04 |
EPS (Diluted) | -0.08 | 0.02 | -0.16 | -0.05 | -0.12 | -0.04 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Free Cash Flow | -9.92 | -3.62 | -7.61 | -4.2 | -21.46 | -2.26 |
Free Cash Flow Per Share | -0.11 | -0.04 | -0.10 | -0.06 | -0.37 | -0.04 |
Gross Margin | -25.85% | - | -50.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -10210.88% | -179875.00% | -53450.00% | -22041.67% | -269600.00% | -874.32% |
Profit Margin | -5120.41% | 43650.00% | -97791.67% | -27300.00% | -117400.00% | -923.73% |
Free Cash Flow Margin | -6749.66% | -90475.00% | -63408.33% | -34958.33% | -357600.00% | -880.55% |
EBITDA | -14.55 | -7.11 | -6.39 | - | -16.15 | -2.24 |
D&A For EBITDA | 0.46 | 0.08 | 0.03 | - | 0.03 | 0.01 |
EBIT | -15.01 | -7.2 | -6.41 | -2.65 | -16.18 | -2.25 |